GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » EV-to-EBIT

Neutra (Neutra) EV-to-EBIT : -2.17 (As of May. 18, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Neutra EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Neutra's Enterprise Value is $0.98 Mil. Neutra's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.45 Mil. Therefore, Neutra's EV-to-EBIT for today is -2.17.

The historical rank and industry rank for Neutra's EV-to-EBIT or its related term are showing as below:

NTRR' s EV-to-EBIT Range Over the Past 10 Years
Min: -59.44   Med: 0   Max: 0
Current: -2.82

NTRR's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.22 vs NTRR: -2.82

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Neutra's Enterprise Value for the quarter that ended in Oct. 2023 was $0.98 Mil. Neutra's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.45 Mil. Neutra's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -46.11%.


Neutra EV-to-EBIT Historical Data

The historical data trend for Neutra's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra EV-to-EBIT Chart

Neutra Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.94 -1.77 -12.95 -4.63 -3.05

Neutra Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.04 -3.05 -2.06 -3.36 -2.17

Competitive Comparison of Neutra's EV-to-EBIT

For the Biotechnology subindustry, Neutra's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neutra's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Neutra's EV-to-EBIT falls into.



Neutra EV-to-EBIT Calculation

Neutra's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.981/-0.452
=-2.17

Neutra's current Enterprise Value is $0.98 Mil.
Neutra's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra  (OTCPK:NTRR) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Neutra's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Oct. 2023 ) =EBIT / Enterprise Value (Q: Oct. 2023 )
=-0.452/0.98037
=-46.11 %

Neutra's Enterprise Value for the quarter that ended in Oct. 2023 was $0.98 Mil.
Neutra's EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Neutra's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra (Neutra) Business Description

Traded in Other Exchanges
N/A
Address
54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243